Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Share-based Compensation (2016 - 2021)

Historic Share-based Compensation for Phio Pharmaceuticals (PHIO) over the last 10 years, with Q4 2021 value amounting to $138000.0.

  • Phio Pharmaceuticals' Share-based Compensation rose 43076.92% to $138000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $480000.0, marking a year-over-year increase of 25294.12%. This contributed to the annual value of $147000.0 for FY2024, which is 5148.51% down from last year.
  • Phio Pharmaceuticals' Share-based Compensation amounted to $138000.0 in Q4 2021, which was up 43076.92% from $143000.0 recorded in Q3 2021.
  • Over the past 5 years, Phio Pharmaceuticals' Share-based Compensation peaked at $165000.0 during Q4 2018, and registered a low of $26000.0 during Q4 2020.
  • Its 5-year average for Share-based Compensation is $75600.0, with a median of $45000.0 in 2017.
  • Its Share-based Compensation has fluctuated over the past 5 years, first tumbled by 8121.21% in 2019, then skyrocketed by 43076.92% in 2021.
  • Phio Pharmaceuticals' Share-based Compensation (Quarter) stood at $38000.0 in 2017, then surged by 334.21% to $165000.0 in 2018, then tumbled by 81.21% to $31000.0 in 2019, then fell by 16.13% to $26000.0 in 2020, then surged by 430.77% to $138000.0 in 2021.
  • Its Share-based Compensation stands at $138000.0 for Q4 2021, versus $143000.0 for Q3 2021 and $132000.0 for Q2 2021.